Brodsky & Smith investigates boards of MarketAxess, CBIZ, Sanara MedTech, and TriCo Bancshares over merger deals

M&A · PartnershipRegulation
โดย GlobeNewswire·Read original
Summary · why it matters

Brodsky & Smith is investigating the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares for potential breaches of fiduciary duty in connection with their respective merger agreements. The investigations concern whether the boards failed to conduct a fair process and whether the proposed transactions pay fair value to shareholders. MarketAxess is being acquired by Intercontinental Exchange for $167 per share in cash, representing an equity value of approximately $6.0 billion. CBIZ is being acquired by Grant Thornton Advisors for $55.00 per share in an all-cash deal with an enterprise value of $5 billion. Sanara MedTech is being acquired by MiMedx Group in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. TriCo Bancshares is being acquired by First Hawaiian in an all-stock deal where TriCo shareholders will receive 2.095 First Hawaiian shares for each TriCo share, representing $63.12 per share based on First Hawaiian's closing price on July 10, 2026.

Impact on stocks 7

Financials▲ · 3 stocks
TriCo Bancshares
TCBK
± MixedRegulationrelevance

Investigation into board's fiduciary duty in merger deal, outcome uncertain.

Industrials▲ · 1 stocks
CBIZ Inc
CBZ
± MixedRegulationrelevance

Investigation into board's fiduciary duty in merger deal, outcome uncertain.

Aging Population▲ · 1 stocks
Sanara Medtech Inc
SMTI
± MixedRegulationrelevance

Investigation into board's fiduciary duty in merger deal, outcome uncertain.

Carbon Removal (DAC)▲ · 1 stocks
Biotech & Genomic Medicine▲ · 1 stocks

Off-coverage companies 1

Grant Thornton AdvisorsPrivate± Mixed
relevance

© 2026 MarketDXNews